Steven Cohen acquired 441 Thousand Aerovate Therapeutics shares worth $9.6 Million. That's 0.03% of their equity portfolio (539th largest holding). The investor owns 1.60% of the outstanding Aerovate Therapeutics stock. The first Aerovate Therapeutics trade was made in Q3 2021. Since then Steven Cohen bought shares two more times and sold shares on three occasions. The stake costed the investor $6.43 Million, netting the investor a gain of 49% so far.